Pages that link to "Q54559603"
Jump to navigation
Jump to search
The following pages link to HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells (Q54559603):
Displaying 50 items.
- Pancreatic cancer stem cell markers and exosomes - the incentive push (Q26741215) (← links)
- Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression (Q26748929) (← links)
- CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting (Q26849606) (← links)
- CD44 as a potential diagnostic tumor marker (Q26866085) (← links)
- CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells (Q28084610) (← links)
- Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells (Q28545737) (← links)
- Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway (Q33657952) (← links)
- microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer (Q33784290) (← links)
- MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer (Q34158964) (← links)
- Assay of lapatinib in murine models of cigarette smoke carcinogenesis. (Q34260243) (← links)
- MicroRNA profile in very young women with breast cancer (Q34468715) (← links)
- MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1. (Q34477508) (← links)
- MicroRNA-139-3p indicates a poor prognosis of colon cancer (Q34733024) (← links)
- Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer (Q35038714) (← links)
- Histone methylation-mediated silencing of miR-139 enhances invasion of non-small-cell lung cancer. (Q36201501) (← links)
- Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression (Q36287390) (← links)
- Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). (Q36426509) (← links)
- The bioinformatics analysis of miRNAs signatures differentially expressed in HER2( ) versus HER2(-) breast cancers (Q36533669) (← links)
- Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells (Q36553388) (← links)
- MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2 (Q36577722) (← links)
- CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression (Q36673977) (← links)
- Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway (Q36962867) (← links)
- miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2. (Q36962950) (← links)
- miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression (Q37400908) (← links)
- miR-139-5p is a regulator of metastatic pathways in breast cancer (Q37448717) (← links)
- Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells (Q37727814) (← links)
- Macro-role of microRNA in gastric cancer (Q38020729) (← links)
- CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches (Q38100108) (← links)
- Chemokines, chemokine receptors and the gastrointestinal system. (Q38109160) (← links)
- MicroRNAs in gastric cancer: from benchtop to bedside (Q38151490) (← links)
- Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128. (Q38189850) (← links)
- MiR-139-5p: promising biomarker for cancer (Q38386331) (← links)
- The Role of CD44 in Disease Pathophysiology and Targeted Treatment. (Q38466771) (← links)
- Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation (Q38514962) (← links)
- Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy (Q38645381) (← links)
- MicroRNA-9 inhibits the gastric cancer cell proliferation by targeting TNFAIP8. (Q38719196) (← links)
- MiR-34a modulates ErbB2 in breast cancer (Q38733014) (← links)
- miR-326 Inhibits Gastric Cancer Cell Growth Through Downregulating NOB1. (Q38812290) (← links)
- Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance (Q38845190) (← links)
- miR-139-5p controls translation in myeloid leukemia through EIF4G2. (Q38854034) (← links)
- CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells. (Q38875316) (← links)
- MicroRNA-506 inhibits gastric cancer proliferation and invasion by directly targeting Yap1. (Q38890422) (← links)
- miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM. (Q38891966) (← links)
- Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of miR-139-5p in human and rat granulosa cells (Q38955458) (← links)
- Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. (Q38979450) (← links)
- Upregulation of microRNA-107 induces proliferation in human gastric cancer cells by targeting the transcription factor FOXO1. (Q39038893) (← links)
- MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells (Q39045296) (← links)
- Epigenetic modulation associated with carcinogenesis and prognosis of human gastric cancer. (Q39321339) (← links)
- Dual-targeting hybrid nanoparticles for the delivery of SN38 to Her2 and CD44 overexpressed human gastric cancer (Q39749680) (← links)
- Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx (Q40492891) (← links)